1-6 of 6
Danielle Roberts
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Impact of Self-Identified Race on Outcomes in Newly Diagnosed Multiple Myeloma (NDMM) Patients Receiving Induction Therapy with Daratumumab, Lenalidomide, Bortezomib and Dexamethasone (D-RVd)

Nisha S. Joseph, Shruti Gupta, Jonathan L. Kaufman, Sara Dicamillo, Danielle Roberts, Vikas A. Gupta, Craig C. Hofmeister, Madhav V. Dhodapkar, Sagar Lonial, Ajay K. Nooka
Journal: Blood
Blood (2024) 144 (Supplement 1): 7870.
https://doi.org/10.1182/blood-2024-211988
Published: 2024
Journal Articles

Efficacy of D-RVD Vs RVD Among t(11;14) Patients with Newly Diagnosed Myeloma

Jonathan L. Kaufman, Nisha S. Joseph, Vikas A. Gupta, Sara Dicamillo, Danielle Roberts, Craig C. Hofmeister, Madhav V. Dhodapkar, Ajay K. Nooka, Sagar Lonial, Lawrence H. Boise
Journal: Blood
Blood (2023) 142 (Supplement 1): 4699.
https://doi.org/10.1182/blood-2023-181783
Published: 2023
Journal Articles

Comparison of Response and Survival Outcomes in Standard- and High-Risk Newly Diagnosed Transplant-Eligible Multiple Myeloma (NDMM) Patients Treated with Lenalidomide, Bortezomib and Dexamethasone (RVD) Versus Daratumumab, Lenalidomide, Bortezomib and Dexamethasone (D-RVD)

Nisha S. Joseph, Jonathan L. Kaufman, Sara Dicamillo, Danielle Roberts, Vikas A. Gupta, Craig C. Hofmeister, Madhav V. Dhodapkar, Lawrence H. Boise, Sagar Lonial, Ajay K. Nooka
Journal: Blood
Blood (2023) 142 (Supplement 1): 647.
https://doi.org/10.1182/blood-2023-187339
Published: 2023
Journal Articles

Bendamustine, Obinutuzumab and Venetoclax Results in High Complete Response Rates in Untreated Mantle Cell Lymphoma

Irl Brian Greenwell, Jeffrey M. Switchenko, Alexander F.M. Craig, Ash A. Alizadeh, Pamela B. Allen, Alicia Escobar, Kelly Valla, Aseala Abousaud, Priya Parikh, Danielle Roberts, Jessica J. Neely, Alexandra Palmer, Kristie A. Blum, Jonathon B. Cohen, Marcela Algave
Journal: Blood
Blood (2022) 140 (Supplement 1): 9373–9374.
https://doi.org/10.1182/blood-2022-167947
Published: 2022
Journal Articles

Bendamustine, Obinutuzumab and Venetoclax As Induction Therapy for Untreated Mantle Cell Lymphoma

Irl Brian Greenwell, MD, Jeffrey M. Switchenko, PhD MS, Kami J. Maddocks, MD, Brad S. Kahl, MD, Alexander F. M. Craig, MPhil, Ash A. Alizadeh, MD PhD, Pamela B. Allen, MD MSc, Alena Lorretta Marbury, BS, Alicia Escobar, Kelly Valla, PharmD, Miayea Williams, Priya Parikh, Danielle Roberts, PA-C, Jessica J. Neely, PA-C, Alexandra Palmer, NP-C, Kristie A. Blum, MD, Jonathon B. Cohen, MDMS
Journal: Blood
Blood (2020) 136 (Supplement 1): 33–34.
https://doi.org/10.1182/blood-2020-141454
Published: 2020
Journal Articles

Evaluation of All Cause of Death after High Dose Chemotherapy and Autologous Stem Cell Transplant in Hodgkin Lymphoma and Non-Hodgkin Lymphoma

Danielle Roberts, PA-C, Subir Goyal, MPH, MBBS, Zhao Chang, PhD, Christopher R Flowers, MD MS, Mary Jo Lechowicz, MD, Amelia Langston, MD, Edmund K. Waller, MD, Sagar Lonial, MD, Pamela Allen, MD MSc, Kristie A. Blum, MD, Jean L. Koff, MD, Jonathan L Kaufman, MD, Ajay K Nooka, MD MPH, Michael Graiser, PhD, Cecilia Rosand, PA-C, Alexandra Palmer, NP-C, Nassoma Bumpers, PA-C, Catherine Fenner, PA-C, Joel O Andrews, PA-C, Caleb J. Raine, MSPAS, PA-C, Jonathon B. Cohen, MD MS
Journal: Blood
Blood (2018) 132 (Supplement 1): 2157.
https://doi.org/10.1182/blood-2018-99-118896
Published: 2018